Zynerba Pharmaceuticals I... (ZYNE)
NASDAQ: ZYNE
· Real-Time Price · USD
1.30
0.03 (2.36%)
At close: Oct 10, 2023, 10:00 PM
Zynerba Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -11.14M | -10.47M | -8.69M | -8.49M | -9.17M | -8.9M | -8.84M | -10.21M | -9.84M | -7.88M |
Interest Income | 434.72K | 447.31K | 407.27K | 251.85K | 91.69K | 96.04K | 4.43K | 5.04K | 5.94K | 5.63K |
Pretax Income | -10.78M | -10.11M | -8.02M | -8.68M | -9.85M | -8.49M | -8.82M | -10.58M | -9.95M | -7.96M |
Net Income | -10.78M | -9.76M | -7.62M | -8.86M | -10.54M | -8.49M | -8.82M | -10.58M | -9.95M | -7.96M |
Selling & General & Admin | 3.97M | 3.39M | 3.22M | 3.45M | 3.72M | 3.76M | 3.81M | 3.87M | 4.39M | 3.28M |
Research & Development | 7.17M | 7.08M | 5.47M | 5.04M | 5.45M | 5.15M | 5.02M | 6.34M | 5.45M | 4.61M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 11.14M | 10.47M | 8.69M | 8.49M | 9.17M | 8.9M | 8.84M | 10.21M | 9.84M | 7.88M |
Interest Expense | n/a | n/a | n/a | 251.85K | 91.69K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 11.14M | 10.47M | 8.69M | 8.49M | 9.17M | 8.9M | 8.84M | 10.21M | 9.84M | 7.88M |
Income Tax Expense | n/a | -357.33K | -399.01K | 183.27K | 684.24K | n/a | -83.27K | n/a | n/a | 76.82K |
Shares Outstanding (Basic) | 50.15M | 48.43M | 45.13M | 43.75M | 41.41M | 40.3M | 40.23M | 40.09M | 40.07M | 40.07M |
Shares Outstanding (Diluted) | 50.15M | 48.43M | 45.13M | 43.75M | 41.41M | 40.3M | 40.23M | 40.09M | 40.07M | 40.07M |
EPS (Basic) | -0.21 | -0.2 | -0.17 | -0.2 | -0.25 | -0.21 | -0.22 | -0.26 | -0.25 | -0.2 |
EPS (Diluted) | -0.21 | -0.2 | -0.17 | -0.2 | -0.25 | -0.21 | -0.22 | -0.26 | -0.25 | -0.2 |
EBITDA | -11.14M | -10.47M | -8.85M | -8.01M | -9.17M | -8.9M | -8.85M | -10.21M | -9.84M | -7.88M |
EBIT | -11.14M | n/a | -8.42M | -8.42M | -9.76M | -8.9M | -8.84M | -10.21M | -9.84M | -7.88M |
Depreciation & Amortization | 65.69K | 141.62K | -262.68K | 486.32K | 829.96K | 60.7K | 61.9K | 61.9K | 61.9K | 61.45K |